You've never seen anything like it · Doors open inStarts at 7:00 PM ET
Skip to content

Bioregulator · Cellular research

Khavinson bioregulators

Also known as peptide bioregulators · cytogens · cytomedins · ultrashort peptides

A family overview: gland-derived peptide extracts and the synthetic two to four residue peptides modeled on them, studied by one research program since the 1970s.

Compound type
Bioregulator
Research area
Cellular

What it is

The bioregulators are a family rather than a single compound. The program behind them, led by Vladimir Khavinson at the St Petersburg Institute of Bioregulation and Gerontology, dates its work to the mid-1970s 1. It began with peptide extracts of animal glands, referred to as cytomedins, which are mixtures of small peptides rather than defined molecules, and moved to synthetic peptides of two to four residues, referred to as cytogens, modeled on what was found in those extracts.

Each synthetic member is a defined peptide with its own formula and reference mass, and each has its own profile: Epitalon is the tetrapeptide AEDG and Bronchogen the tetrapeptide AEDL, and the family also includes dipeptides and tripeptides. The gland extracts are mixtures and have no single mass.

Structure and chemistry

The synthetic members are built from a narrow set of residues, mostly alanine, glutamic acid, aspartic acid, lysine, glycine, arginine and occasionally tryptophan, with masses roughly between 200 and 600 g/mol. That places them closer to small-molecule than to peptide chemistry in handling terms.

Acidic side chains predominate in several members, so those peptides are negatively charged at neutral pH, while the lysine-containing members are positively charged. None contains cysteine, so there is no disulfide chemistry, and most contain no aromatic residue, so ultraviolet absorbance above 220 nm is negligible and chromatographic detection is usually at low wavelength. Sequences containing aspartic acid are susceptible to aspartimide formation under basic conditions.

How it is studied in the laboratory

Most of the published work comes from the originating program. Its central proposal is that peptides of two to seven residues regulate gene expression and protein synthesis, a position the group set out in a systematic review of its own work 4. A separate review from the same group used molecular modeling and published transporter data to argue that such peptides could enter cells through POT family carriers, PEPT1, PEPT2, PHT1 and PHT2, and through LAT carriers 3.

Cell-culture work includes organotypic culture studies measuring the expression of signaling molecules after exposure to short peptides 5. The main animal study cited for the family examined Epitalon in female SHR mice, measuring age-related biomarkers, survival and spontaneous tumor incidence 6. An independent review by chemists outside the program collected the published work on Epitalon and noted that structural and physicochemical study of the molecule remains limited 2.

Analytical notes

Each synthetic member is confirmed separately by liquid chromatography coupled to mass spectrometry against its own expected ions, with the relevant values on the individual profiles. The gland extracts cannot be handled this way: as mixtures they have no single expected mass, and characterization depends on separation profiles and total peptide content rather than on one identity peak. Short, polar peptides of this kind are weakly retained on standard C18 columns, so ion pairing or HILIC is usually needed.

Storage and handling in the laboratory

The synthetic members are supplied as lyophilized powders, stored at -20 degrees Celsius, sealed and protected from light and moisture. Counter-ion content is proportionally large for peptides of this mass and should be accounted for in gravimetric standards.

Open questions in the literature

Independent replication is the main gap: the great majority of primary work on this family comes from the originating group, and the independent review that exists describes the structural and physicochemical characterization as limited 2. The proposed cell entry route rests on modeling and on transporter data for peptides in general rather than on measurement of a specific bioregulator inside cells 3.

References

  1. Khavinson VKh, Anisimov VN. [35-year experience in research of peptide regulation of aging]. Advances in Gerontology. 2009;22(1):11-23. Source
  2. Araj SK, Brzezik J, Madra-Gackowska K, Szeleszczuk L. Overview of Epitalon, a highly bioactive pineal tetrapeptide with promising properties. International Journal of Molecular Sciences. 2025;26(6):2691. doi:10.3390/ijms26062691. Source
  3. Khavinson V, Linkova N, Kozhevnikova E, Dyatlova A, Petukhov M. Transport of biologically active ultrashort peptides using POT and LAT carriers. International Journal of Molecular Sciences. 2022;23(14):7733. doi:10.3390/ijms23147733. Source
  4. Khavinson VK, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide regulation of gene expression: a systematic review. Molecules. 2021;26(22):7053. doi:10.3390/molecules26227053. Source
  5. Khavinson VKh, Linkova NS, Chalisova NI, Dudkov AV. Effect of short peptides on expression of signaling molecules in organotypic pineal cell culture. Bulletin of Experimental Biology and Medicine. 2011;152(1):138-141. doi:10.1007/s10517-011-1473-y. Source
  6. Anisimov VN, Khavinson VKh, Popovich IG, Zabezhinski MA, Alimova IN, Rosenfeld SV. Biogerontology. 2003;4:193-202. doi:10.1023/a:1025114230714. Source

For laboratory research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure, or prevent any disease.